Help us make childhood cancer universally survivable.
By giving monthly, you directly support our continued research into discovering effective and less toxic treatments for childhood cancer.
Our team is on a mission to make childhood cancer universally survivable!
The FDA approves on average 12 drugs every year to treat adult cancer, but has only approved 13 drugs to treat childhood cancer since 1978 (13 in 47 years for kids).
Since our inception in 2015, cc-TDI has pushed two drugs into three clinical trials to treat childhood cancer.
giving back childhood for Sophie Shane Thomas Alexa Cooper Joseph Addie Finn Bode Hunter George Zack Samara
#GIVINGBACKCHILDHOOD
Latest News
Re-invest in Research
This year marks 10 years of innovation and progress at cc-TDI, and we’re proud to reflect on the milestone we’ve reached—because of you. Despite a decade of incredible progress, we’re facing an urgent challenge that threatens to slow the momentum we’ve built together. As a nonprofit that relies on a network of public and private support, our funding is not guaranteed. And right now, there’s a critical gap—one that puts the development of new therapies at risk. To address this, we’ve launched the Research Continuity Fund, an urgent initiative to ensure our work continues without
10 Year Impact Report!

cc-TDI Partners with NIH on RMS

Our hero, Abby: A Parent’s Heartfelt Journey
2025 Summer Internship Opportunities!
In the Press
Current Research Projects

A dedicated research team
Our research team is exploring and testing state-of-the-art treatment options for the most urgent issues facing children with cancer.
Working in our own freestanding research institution allows us to act swiftly and nimbly to achieve results—bringing cost control, speed, purpose, and focus to translate effective treatments into the clinic. To get there, we perform basic science and translational research in our industrial modern lab site (a paint factory remodeled by Nike as an off-site creative space), adjacent to the Silicon Forest in Oregon.